No Data
No Data
Market movements | Weikang Brain Science rose by over 5%, Nanjing Panda Electronics rose by nearly 5%, and the Brain-computer Interface is expected to gradually achieve commercial application.
In terms of news, Professor Jin Jing's research team from East China University of Science and Technology released the latest research achievement, "A Mixed Reality Enhanced Brain-Machine Interface System for Quadrupedal Control," which is expected to enable quadruped Siasun Robot&Automation to perform dangerous search and rescue tasks.
Micro-invasive Brain Science (02172) rose by 10.03% against the market trend. Institutions indicate that the Brain-computer Interface Industry is likely to gradually achieve commercial application.
Jinwu Financial News | Microworks Neuroscience (02172) is performing strongly against the market, with a 10.03% increase in weight loss, priced at 14.72 Hong Kong dollars, with a transaction volume of 0.104 billion yuan. In terms of information, China Securities Co.,Ltd. released a Research Report stating that technological advancements in the midstream of the Brain-computer Interface Industry Chain are leading to continuous breakthroughs in downstream applications. In recent years, both domestic and international research in the Medical fields of sports recovery, language communication, and hearing reconstruction have achieved milestone results. At the national and regional levels, many policies have been introduced to provide Bullish support for the industry's accelerated development. Recently, the National Medical Insurance Administration issued a document for the new pricing item of Brain-computer Interface technology, and the service charge pathway for its clinical application has now been established.
Micron Neuroscience (02172.HK) will hold a Board of Directors meeting on March 26 to approve the annual performance.
Gelonghui reported on March 14 that Micron Brain Science (02172.HK) announced that the Board of Directors will hold a meeting on March 26, 2025, to approve the company's and its subsidiaries' annual performance announcement for the year ending December 31, 2024, and to consider the proposal for the final dividend distribution (if any).
MICROPORT NEURO: DATE OF BOARD MEETING
Hong Kong Stock Afternoon Review | Hang Seng Index rose 2.55% in the morning session, Microinvasive Group surged.
The MICROPORT sector collectively surged, with MICROPORT Neuroscience (02172) rising over 25% during the session, and JPMorgan is bullish on MICROPORT achieving profitability in 2026.
Hong Kong stocks movement | The MICROPORT system collectively soared, with MICROPORT Neuroscience (02172) rising over 25% during the trading session. Morgan Stanley is bullish on MICROPORT achieving profitability by 2026.
The MICROPORT sector is rising collectively; as of the time of writing, MICROPORT Neuroscience (02172) has increased by 20.4%, trading at HKD 13.1; MICROPORT (00853) has risen by 14.58%, trading at HKD 8.88; MEDBOT-B (02252) has risen by 1.97%, trading at HKD 20.7; CARDIOFLOW-B (02160) has risen by 1.82%, trading at HKD 1.12.